|
Search
Collections
Benchmarks
Upload document
Product
RB/RBAC
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
mantle cell lymphoma
Clinical trial
A Randomized Phase II Trial Comparing Rituximab/Bendamustine(RB) Alternating With Rituximab/Bendamustine/Cytarabine(RBAC) With RB as Induction Therapy in Elderly Patients With Newly Diagnosed and Transplant-ineligible Mantle Cell Lymphoma
Status: Recruiting
, Estimated PCD: 2029-12-31